AI assistant
Sending…
Medtronic plc — Director's Dealing 2015
Aug 5, 2015
29841_dirs_2015-08-05_2dfa8663-d0f1-4cf5-a896-ee272b9acb7f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2015-08-03
Reporting Person: Ellis Gary Lee (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-03 | Ordinary Shares | A | 18697 | — | Acquired | 174021 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-03 | Employee Stock Option (right to buy) | $78 | A | 74787 | Acquired | 2025-08-03 | Ordinary Shares (74787) | Direct |
| 2015-08-03 | Employee Stock Option (right to buy) | $78 | A | 1283 | Acquired | 2025-08-03 | Ordinary Shares (1283) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 5137 | Indirect |
| Ordinary Shares | 7699 | Indirect |
Footnotes
F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2018 equals or exceeds a 3% compound annual growth rate, as determined by the Compensation Committee.
F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
More from Medtronic plc
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 18
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Interim / Quarterly Report
2026
Feb 24
Regulatory Filings
2026
Feb 17
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Jan 29
Major Shareholding Notification
2026
Jan 29